Parabolan 100

Product Description

Parabolan 100 refers to an injectable formulation associated with trenbolone hexahydrobenzylcarbonate, a long-acting ester of trenbolone. The compound belongs to the anabolic-androgenic steroid (AAS) class and has potent androgen-receptor activity.

Trenbolone was developed primarily for veterinary applications, while trenbolone hexahydrobenzylcarbonate has historically been associated with the former pharmaceutical product Parabolan. It is not an approved human therapeutic anabolic steroid in many jurisdictions today.

Product Information

Active Compound: Trenbolone Hexahydrobenzylcarbonate
Common Name: Parabolan
Category: Anabolic-Androgenic Steroid (AAS)
Form: Injectable
Strength: 100 mg/mL
Ester: Hexahydrobenzylcarbonate

Pharmacological Overview

Trenbolone hexahydrobenzylcarbonate is a long-acting androgen ester. After administration, the ester is metabolized to trenbolone, which binds to androgen receptors and produces potent androgenic and anabolic activity.

Potential Risks & Considerations

Trenbolone exposure may be associated with suppression of natural testosterone production, adverse changes in cholesterol, elevated cardiovascular risk, acne, hair loss, mood changes, and reproductive effects. The long-term effects of non-medical human exposure are not well established.